Long-Term Statin Use, Total Cholesterol Level, and Risk of Colorectal Cancer: A Prospective Cohort Study

Timing of aspirin use in colorectal cancer chemoprevention: a prospective cohort study

(2021) Yin Zhang et al.   JNCI-Journal of the National Cancer Institute

Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum

(2020) Liang Wang et al.   GASTROENTEROLOGY

Gut bacterial microbiome composition and statin intake—A systematic review

(2020) Andreia M. Dias et al.   Pharmacology Research & Perspectives

Emulating a target trial in case-control designs: an application to statins and colorectal cancer

(2020) Barbra A Dickerman et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients

(2019) Ka-Shing Cheung et al.   GUT

Statin use and site-specific risk of colorectal cancer in individuals with hypercholesterolemia from the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS)

(2019) Jae-Woo Lee et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Chemoprevention of Colorectal Cancer

(2019) Bryson W. Katona et al.   GASTROENTEROLOGY

Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer

(2019) Mingyang Song et al.   GASTROENTEROLOGY

Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause

(2019) Gemma Ibáñez-Sanz et al.   Scientific Reports

Statin use and the risk of colorectal cancer in a population-based electronic health records study

(2019) Gemma Ibáñez-Sanz et al.   Scientific Reports

Modifiable pathways for colorectal cancer: a mendelian randomisation analysis

(2019) Alex J Cornish et al.   Lancet Gastroenterology & Hepatology

Aspirin and Delayed Chemoprevention of Colorectal Cancer

(2018) Edward Giovannucci   CLINICAL CHEMISTRY

Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease

(2018) Shailja C. Shah et al.   Gut and Liver

Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer

(2017) Henry Rodriguez-Broadbent et al.   INTERNATIONAL JOURNAL OF CANCER

Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study

(2017) David Renman et al.   World Journal of Surgical Oncology

Blood Lipid Concentrations and Colorectal Adenomas: A Systematic Review and Meta-Analysis of Colonoscopy Studies in Asia, 2000–2014

(2016) Michael N. Passarelli et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force

(2016) Jessica Chubak et al.   ANNALS OF INTERNAL MEDICINE

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Kirsten Bibbins-Domingo et al.   ANNALS OF INTERNAL MEDICINE

Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases

(2016) Ashwin N. Ananthakrishnan et al.   Clinical Gastroenterology and Hepatology

Statin use and the risk of colorectal adenoma: A meta-analysis

(2016) Yoon Suk Jung et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Statin use and the risk of developing diabetes: a network meta-analysis

(2016) Divyesh Thakker et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study

(2016) Ju-Chi Liu et al.   Oncotarget

Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study

(2016) Ronac Mamtani et al.   PLOS MEDICINE

Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer

(2016) Yin Cao et al.   JAMA Oncology

Plasma lipid levels and colorectal adenoma risk

(2015) John-Anthony Coppola et al.   CANCER CAUSES & CONTROL

Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden

(2014) Linda Björkhem-Bergman et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Statins and the risk of colorectal cancer: An updated systematic review and meta-analysis of 40 studies

(2014) Theodore Lytras   WORLD JOURNAL OF GASTROENTEROLOGY

Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial

(2013) Nancy R. Cook et al.   ANNALS OF INTERNAL MEDICINE

Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies

(2013) Yanqiong Liu et al.   CANCER CAUSES & CONTROL

Statins and Colorectal Cancer

(2012) Paul Lochhead et al.   Clinical Gastroenterology and Hepatology

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Statin Use and Colorectal Cancer Risk According to Molecular Subtypes in Two Large Prospective Cohort Studies

(2011) J. E. Lee et al.   Cancer Prevention Research

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

(2009) Jack Cuzick et al.   LANCET ONCOLOGY

Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men

(2007) Andrew T. Chan et al.   GASTROENTEROLOGY